NeuroOne Medical Technologies Corporation (NMTC)

USD 0.74

(-6.41%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 1.95 Million 171.16 Thousand 178.14 Thousand 1.92 Million - -
Cost of Revenue 1.49 Million 241.96 Thousand 275.89 Thousand 1.86 Million 27.56 Thousand 21.66 Thousand
Gross Profit 456.51 Thousand -70.79 Thousand -97.74 Thousand 63.11 Thousand -27.56 Thousand -21.66 Thousand
Operating Expenses 12.41 Million 9.95 Million 10.12 Million 4.9 Million 5.81 Million 3.18 Million
Selling, General and Administrative Expenses 6.92 Million 6.97 Million 6.26 Million 4.75 Million 4.28 Million 3.53 Million
Research and Development Expenses 6.94 Million 4.92 Million 3.92 Million 2.07 Million 1.52 Million 951.06 Thousand
Other Expenses - 31.15 Thousand 271.12 Thousand - - 1.3 Million
Cost and Expenses 13.9 Million 10.2 Million 10.39 Million 4.9 Million 5.81 Million 3.21 Million
Operating Income -11.95 Million -10.03 Million -10.21 Million -4.9 Million -5.81 Million -3.21 Million
Interest Expense - - 3053.00 7.52 Million 284.55 Thousand -
Income Tax Expense - -109.86 Thousand 274.17 Thousand 7.52 Million 284.55 Thousand 3.00
Earnings before Tax -11.85 Million -9.99 Million -9.94 Million -13.64 Million -6.78 Million -6.82 Million
Net Income -11.85 Million -9.99 Million -9.94 Million -13.64 Million -6.78 Million -6.82 Million
Earnings Per Share Basic -0.65 -0.63 -0.93 -2.52 -1.72 -2.43
Earnings Per Share Diluted -0.65 -0.63 -0.93 -2.52 -1.72 -2.43
Weighted Average Shares Outstanding 18.12 Million 15.99 Million 10.69 Million 5.41 Million 3.95 Million 2.8 Million
Weighted Average Shares Outstanding (Diluted) 18.12 Million 15.99 Million 10.69 Million 5.41 Million 3.95 Million 2.8 Million
Gross Margin 0.23 -0.41 -0.55 0.03 - -
EBIT Margin -6.02 -57.91 -55.38 -2.52 - -
Profit Margin -6.07 -58.42 -55.84 -7.08 - -
EBITDA -11.75 Million -9.91 Million -9.79 Million -4.85 Million -5.78 Million -4.14 Million
Earnings Before Tax Margin -6.12 -58.60 -57.36 -2.54 - -

Income Statement Charts